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A central function of our innate immune system is to sense microbial 
pathogens through the presence of their 
nucleic acid genomes or their transcrip-
tional or replicative activity. In mam-
mals, a receptor-based system is mainly 
responsible for the detection of these 
“non-self” nucleic acids. Tremendous 
progress has been made in the past years 
in identifying the host constituents that 
are required for this intricate task. With 
regard to the sensing of RNA genome 
based pathogens by our innate immune 
system, a picture is emerging that includes 
certain families of the toll-like receptor 
family (TLR3, TLR7, TLR8) and the 
RIG-I like helicases (RIG-I, MDA5 and 
LGP2). Genetic loss of function studies 
implicate that the absence of these path-
ways can lead to a complete lack of rec-
ognition of certain RNA viruses. At the 
same time, intracellular DNA can also 
trigger potent innate immune responses, 
yet the players in this field are less clear. 
We and another group have recently 
identified a role for RNA polymerase III 
in the conversion of AT-rich DNA into an 
RNA ligand that is sensed by the RIG-I 
pathway. In this review article, we will 
discuss the mechanisms and implications 
of this novel pathway.
Introduction
The integrity of every living organism is 
under constant threat of attack from the 
microorganisms in its immediate environ-
ment. To this effect, most organisms have 
evolved efficient strategies to counteract 
the mere presence or the transcriptional 
and replicative activity of foreign genetic 
material. For example, in both plants and 
invertebrates, one central mechanism 
of antiviral defense is RNA interference 
(RNAi), where viral double-stranded 
RNA (dsRNA) is targeted by RNase III 
enzymes of the Dicer family and subse-
quently cleaved into small dsRNA frag-
ments of 21 nucleotides in length. These 
RNA fragments are incorporated into 
the RNA-induced silencing complex 
and finally serve as a “template” for the 
highly specific cleavage of virus-encoded 
RNAs. In nematodes and plants, the anti-
viral activity of siRNA is further ampli-
fied through the secondary production 
of siRNAs that are generated by RNA-
dependent RNA polymerases. In higher 
organisms, a receptor-based anti-micro-
bial innate immune system seems to have 
replaced the RNAi-based defense system, 
yet nucleic acids also play a key role here. 
Pattern-recognition receptors (PRRs) have 
evolved to detect the presence of “foreign” 
genetic material, and, following ligand 
recognition, these receptors trigger the 
nuclear translocation of key transcription 
factors that control the expression of anti-
microbial effector genes. In the mamma-
lian system, the main antiviral response 
is controlled by the production of type I 
interferons. The expression of this gene 
family mainly depends on the recogni-
tion of virus-derived nucleic acids through 
PRRs. Ultimately, these cytokines provoke 
the eradication of the invading patho-
gen and simultaneously regulate adaptive 
immune responses (reviewed in ref. 1).
Although several types of PRRs have 
been identified, the family of TLRs is 
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responses.10,11 While some signaling mol-
ecules of the dsDNA-induced signaling 
pathway have been identified, the actual 
receptor systems that trigger these path-
ways are less clear. A candidate DNA 
receptor DAI (DNA-dependent activa-
tion of interferon regulatory factors) has 
been considered to be potential DNA 
sensor. However, DAI-deficient mice pro-
duce normal amounts of type I interferon 
in response to dsDNA.12-14 In addition, 
we and three other groups recently char-
acterized AIM2 (Absent In Melanoma 2) 
as a cytosolic DNA receptor that induces 
the induction of Interleukin-1β via the 
inflammasome pathway.15-18 However, 
AIM2 is not involved in the produc-
tion of type I interferon. Furthermore, 
an issue that has remained controversial 
is the contribution of RIG-I and its sig-
naling molecule MAVS (also known as 
IPS-1, Cardif, VISA) to dsDNA-induced 
type I interferon responses. The initial 
report that had shown that transfection 
of dsDNA can induce potent type I IFN 
responses implicated a requirement for 
MAVS in this pathway.10 In this respect, 
it was speculated that, in analogy to 
RIG-I and MDA5, the putative dsDNA 
receptor employed MAVS as a signaling 
molecule. In this study, AT-rich dsDNA 
(poly(dA:dT)) was used to induce type 
I IFN production in HEK 293 cells, and 
MAVS was silenced using siRNA. Another 
study went on to implicate RIG-I directly 
in the recognition of dsDNA. Again, 
AT-rich dsDNA was used to trigger type 
I production in a human cell line and the 
involvement of RIG-I was shown by using 
a cell line that is devoid of functional 
RIG-I.19 However, the theory that RIG-I 
and MAVS were required for dsDNA rec-
ognition was challenged by several reports 
that showed that MAVS- and RIG-I-
deficient mice presented completely nor-
mal antiviral responses following dsDNA 
transfection.20,21
Intracellular DNA Induces  
the Production of a Stimulatory 
RNA Intermediate
Recently, we and another group were able 
to reconcile some of the controversies 
with regard to the involvement of RIG-I 
and MAVS in dsDNA-induced type I 
transcript or dephosphorylation prevented 
detection by RIG-I. As these modifications 
naturally occur during the maturation of 
endogenous RNA transcripts but not in 
the course of the viral, cytosolic replication 
processes, the presence of a 5'-triphosphate 
group marked an important molecular 
structure that allows the host to discrimi-
nate self from “foreign” RNA.
Another hallmark of “foreign” RNA is 
double-strandedness. While short stretches 
of dsRNA can be present under physi-
ological conditions, longer dsRNA with 
complete base pairing is usually not found 
in non-infected cells. In this regard, it is 
now well established that MDA5 senses 
dsRNA species. However, two indepen-
dent reports have shown that RIG-I also 
requires dsRNA stretches for its activity.8,9 
Until then, knowledge about the stimula-
tory elements of RIG-I ligands was mostly 
drawn from studies with 5'-triphosphate 
RNA generated by in vitro transcription. 
Using well-defined, chemically synthesized 
5'-triphosphate RNA, Schlee et al. and 
Schmidt et al. showed that single-stranded 
5'-triphosphate RNA was not able to trig-
ger the production of type I interferon 
via RIG-I. Instead, aberrant dsRNA by-
products naturally emerging during the in 
vitro transcription process were found to 
be responsible for the activation of RIG-I. 
These immunologically active triphospho-
rylated dsRNAs are generated as a result of 
self-coding intramolecular 3'extension and 
RNA-template-coded de novo synthesis. A 
thorough investigation of the characteris-
tics of stimulatory RNAs further revealed 
that a blunt-end formation at the 5'-triphos-
phate end yielded maximal activity, while 
overhangs at the 5'-triphosphate end were 
not tolerated by RIG-I.8 Accordingly, base 
pair mismatches in the first position of the 
complementary RNA strand (opposite the 
5'-triphosphate end) markedly reduced the 
activity. Thus, both the 5'-triphosphate end 
and double-stranded, blunt-ended RNA-
stretches synergize to activate RIG-I.
Double Stranded DNA Triggers 
Potent Antiviral Responses
In addition to dsRNA, dsDNA can also 
serve as a pathogen-associated molecu-
lar pattern, and its intracellular recogni-
tion triggers very strong type I interferon 
the group that has been best characterized 
so far. TLR3, TLR7, TLR8 and TLR9 
participate in antiviral immunity by rec-
ognizing dsRNA, ssRNA and CpG-rich 
DNA in the endosomes of dendritic cells 
and macrophages, respectively.2 In addi-
tion to TLRs, intracellular receptors also 
detect virus-associated nucleic acids. One 
such receptor is the double-stranded RNA-
activated protein-kinase PKR, which senses 
dsRNA.3 However, the role of PKR in ini-
tiating antiviral immunity has remained 
controversial. In 2004, Fujita and col-
leagues expanded the repertoire of intrac-
ellular PRRs by identifying the DexD/H 
box Helicase RIG-I as a cell-autonomous 
sensor of dsRNA arising during virus infec-
tion.4 Following this landmark discovery, 
the family of antiviral RNA helicases was 
expanded to RIG-I, MDA5 and LGP2, 
and this group of proteins is often referred 
to as RIG-I like helicases (RLH). An over-
view of currently known nucleic acid sens-
ing pathways is depicted in Figure 1.
RNA Recognition by RIG-I-Like 
Helicases
While the RLHs share a common recep-
tor architecture, they differ in their ligand 
specificity and, thus, their role in the set-
ting of RNA virus infection. Studies using 
RIG-I deficient mice have demonstrated 
that RIG-I is essential for the type I inter-
feron response to the negative-stranded 
viruses, such as paramyxoviruses, VSV 
and the influenza virus.5 MDA5-deficient 
mice, however, are highly susceptible to 
infection with Picornaviruses, such as 
Encephalomyocarditis virus or Theiler’s 
virus, which have positive-sense genomes.
The distinct preference for virus rec-
ognition by RIG-I and MDA5 is reflected 
by their different ligand specificities. In 
an attempt to characterize the molecular 
ligand for RIG-I, it was first noticed that 
long homopolymeric dsRNA (Poly(I:C)) 
was recognized by MDA5 while RIG-I 
seemed to detect shorter RNAs.5 In 2006, 
we and another group independently 
observed that a 5'-triphosphate moiety was 
essential for the activation of RIG-I and 
that this structure represents the molecular 
substrate that renders in vitro transcribed 
RNA immunostimulatory.6,7 Base modifi-
cations, capping at the 5' end of the RNA 
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Figure 1. Nucleic acid recognition pathways that lead to activation of central transcription factors in innate immunity. the best studied nucleic acid 
sensing pathway of the innate immune system is the family of toll-like receptors. of these, tLR3 (A), located at the cell surface, recognizes dsRNA. tLR7 
and tLR8 are confined to endolysosomal compartments, where they sense ssRNA or short dsRNA (B). tLR9, on the other hand, recognizes DNA with a 
strong preference for sequence motifs containing unmethylated CG dinucleotides (C). in the cytoplasm the family of RiG-i like helicases senses RNA 
with certain structural features (D). RiG-i is activated by short dsRNA with a 5' triphosphate RNA moiety, whereas MDA5 recognizes long dsRNA. LGP2, 
which is structurally highly similar to RiG-i and MDA5, yet devoid of a signaling domain, seems to play a modulating role on both RiG-i and MDA5. 
Next to the RiG-i like helicase family, NoD2 was recently implicated as an additional sensor for cytosolic RNA (e). Cytoplasmic DNA recognition is less 
well understood. DAi was recently implicated as a cytoplasmic DNA sensor, but studies with DAi-deficient mice suggest that its function is redundant 
(f). RNA Pol iii indirectly contributes to innate immune sensing by transcribing At rich dsDNA into a RiG-i ligand (G). the exact localization of this 
pathway, cytoplasm vs. nucleus, is not yet completely solved. in addition, it is very likely that additional sensing pathways exist that contribute to 
cytoplasmic DNA recognition (H).
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completed and the nascent transcript has 
been released from the transcription com-
plex. Some Pol III transcripts undergo elab-
orate processing, such as tRNAs, which are 
nucleolytically processed and finally exhibit 
a 5'monophosphate. U6 snRNA retains a 
5'triphosphate but is O-methylated at the 
terminal phosphate.25 The proper modifi-
cation of this RNA transcript depends on 
the presence of a conserved stem-loop in a 
certain sequence context. Thus, transcripts 
that are artificially transcribed downstream 
of the U6 promoter (e.g., shRNAs) are not 
modified at their 5' end.26 Some natural 
Pol III transcripts are modified to a lesser 
extent and some, such as 5S rRNA, retain 
the 5'-triphosphate terminus of the primary 
transcript. Since a 5'-triphosphate moiety is 
a prerequisite for the activation of RIG-I, 
unmodified RNA Pol III transcripts are per 
se potential candidates for the source of the 
stimulatory RNA intermediate.
In retrospect, an intriguing first link 
between the production of type I interferon 
and RNA Pol III transcripts had already 
been described before, when Iggo and col-
leagues first demonstrated that H1- and 
U6-promoter driven shRNAs, which are 
known products of RNA Pol III, are able 
to trigger type I interferon.27 Although 
from their studies it was clear that certain 
shRNA sequences exhibited strong inter-
feron-inducing effects, the cellular pro-
cesses underlying this response remained 
unknown.
Nevertheless, a fundamental differ-
ence between RNA Pol III driven shRNA 
construct and poly(dA:dT) is marked 
by the absence of a classical promoter-
sequence within poly(dA:dT) that would 
allow specific recruitment of the RNA 
Pol III transcription machinery. However, 
homopolymeric poly(dA:dT) sequences are 
widely used to study promoter-independent 
transcription. Interestingly, of the three 
eukaryote RNA polymerases, the prefer-
ence for poly(dA:dT) as a template has 
been reported to be highest for RNA Pol 
III.28
Promoter-Independent  
Transcription of AT-Rich dsDNA  
by RNA Pol III
On the basis of these indications, we 
focused our investigations on RNA Pol III. 
that poly(dA:dT) might by transcribed 
into poly(rA:rU) by a DNA-dependent 
RNA polymerase.
Transcription by Endogenous  
DNA-Dependent RNA Polymerases
In eukaryotes, transcription is carried out 
by three distinct DNA-dependent RNA 
polymerases, known as RNA Pol I, Pol II 
and Pol III. These RNA Polymerases are 
multisubunit enzyme complexes that share 
a structurally conserved core, yet they differ 
in the composition of subunits located at the 
outer part of the transcription complex.24 
Each RNA Pol catalyzes the transcription 
of a specific set of genes. RNA Pol I synthe-
sizes one large, single precursor ribosomal 
RNA (rRNA), which is processed into 18S 
rRNA, 5.8S rRNA and 28S rRNA. In con-
trast, RNA Pol II-mediated transcription 
is very complex and includes the synthesis 
of all protein-encoding mRNAs as well as 
non-protein coding RNAs (ncRNAs), such 
as small nuclear RNAs (snRNAs), small 
nucleolar RNAs (snoRNAs) and micro 
RNAs (miRNAs). Conceptually, RNA Pol 
III more closely resembles RNA Pol I as it 
is responsible for transcription of ncRNAs. 
The list of RNAs transcribed by RNA Pol 
III includes but is not limited to tRNA, 5S 
rRNA, snRNAs, snoRNAs, miRNAs and 
Piwi-interacting RNAs.
The primary transcripts of all three RNA 
Polymerases bear a 5'-triphosphate end as 
soon as they emerge from the polymerase 
complex. However, this triphosphate end is 
often removed or modified by RNA modi-
fying enzymes. For instance, RNA Pol I 
synthesized precursor-rRNA undergoes 
multiple exo- and endonucleolytic cleav-
ages, the net result being that ribosomal 
RNAs bear a 5'-monophosphate group. 
Primary RNA Pol II transcripts obtain a 
characteristic 7-methyl-guanosine residue at 
the 5' end. The addition of this cap occurs 
during the transcription process, when the 
nascent transcript encompasses roughly 
30 nucleotides and involves the catalytic 
activity of a RNA-triphosphatase, a gua-
nylyltransferase and a methyltransferase, 
respectively. Unlike pre-mRNA, RNA 
Pol III transcripts are synthesized without 
RNA modifications or processing. Instead, 
the maturation of RNA Pol III tran-
scripts takes place after synthesis has been 
interferon production.22,23 Indeed, we 
were able to show that beyond its function 
in the transcription of non-coding RNAs, 
DNA-dependent RNA Polymerase III 
(RNA Pol III) participates in DNA-
triggered innate immunity by converting 
AT-rich DNA into a RIG-I stimulatory 
RNA intermediate. Recognition of this 
intermediate RNA species via RIG-I then 
goes on to stimulate the production of 
interferon.
In an attempt to study the function 
of different RNA sensors in the recogni-
tion of the negative-strand ssRNA virus 
Sendai Virus (SEV), we unexpectedly 
observed that the control stimulus, the 
synthetic dsDNA mimetic poly(dA:dT) 
induced type I interferon in a RIG-I- and 
MAVS-dependent fashion. It is impor-
tant to note that this RIG-I dependency 
was not observed in primary murine 
macrophages or bone-marrow-derived 
dendritic cells, suggesting that in these 
cell populations at least one other path-
way must exist in parallel. As mentioned 
above, the notion that RIG-I, which is a 
bona fide RNA sensor, would also respond 
to dsDNA seemed to be counterintuitive 
at first sight. Searching for an explana-
tion for this puzzle, we noticed a slight 
delay in the induction of type I interferon 
when using dsDNA in comparison to the 
established RIG-I ligand 5' triphosphate 
RNA. We thus considered the possibil-
ity that poly(dA:dT) might somehow 
induce an intracellular RNA intermedi-
ate that served as a RIG-I activator. The 
simplest approach to searching for stimu-
latory RNA intermediates was the isola-
tion of nucleic acids derived from cells 
transfected with poly(dA:dT) in order to 
assess their immunostimulatory potential. 
Indeed, using this approach we found 
that poly(dA:dT) triggered the de novo 
synthesis of a stimulatory RNA species. 
We then tried to ascertain the nature of 
this RNA ligand by screening a variety of 
RNA modifying enzymes for their impact 
on the interferon-inducing activity of this 
stimulatory RNA. These experiments 
revealed that transfection of poly(dA:dT) 
triggered synthesis of a dsRNA interme-
diate that contained a 5' triphosphate end 
and was devoid of guanosine. Since such 
a dsRNA species could consist of adenos-
ines and uracils, we formed the hypothesis 
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cognate DNA template. Due to extensive 
studies in the model organism Saccharomyces 
cerevisiae, there is a detailed understand-
ing of the subunits that together form the 
the contribution of single RNA Pol III sub-
units, we found that two subunits, namely 
RPC3 and RPC7 were dispensable for de 
novo synthesis of poly(rA:rU) from the 
We observed that AT-rich DNA sequences 
are converted in vivo into poly(rA:rU) tran-
scripts and that RNA Pol III is responsible 
for this effect. Remarkably, while studying 
Figure 2. innate immune sensing by RNA polymerase iii. RNA Pol iii can transcribe DNA of various sources in a promoter-dependent or promoter-
independent fashion. (A) At-rich DNA, e.g., poly(dA:dt), when transfected into certain cells is transcribed by RNA Pol iii in a promoter-independent 
fashion. the resulting RNA transcript poly(rA:rU) that activates RiG-i has been identified by direct an indirect methods. in addition, synthetic RNA Pol 
iii genes such as shRNAs that are transcribed in a promoter-dependent manner can yield RNA transcripts that are highly RiG-i stimulatory. (B) A similar 
scenario holds true for epstein-Barr-Virus, where virus encoded RNA Pol iii transcripts are sensed by RiG-i. Moreover, Chiu et al. have shown that HSV-1, 
that doesn’t harbor known RNA Pol iii transcribed genes, triggers type i ifN in an RNA Pol iii dependent fashion. (C) intracellularly replicating bacteria, 
such as Legionella pneumophila, have also been reported to trigger the RNA Pol iii—RiG-i pathway for type i ifN induction by Chiu and colleagues. 
important questions that remain unanswered for these observations are the localization of the RNA Pol iii-mediated transcription and the nature of 
the RNA transcripts being made.
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by RIG-I is prevented. Still, some viruses 
from the herpes family of DNA viruses 
have been reported to encode for structural 
RNAs harboring an unmodified, “free” 
triphosphate end. This is, for instance, 
the case for RNA Pol III transcribed EBV-
encoded RNA 1 (EBER-1) and EBER-2 
derived from Epstein Bar Virus. In contrast 
to poly(dA:dT), the transcription of the 
EBER gene locus is accomplished through 
promoter-directed transcription involving 
specific RNA Pol III promoters sites thus 
resembling the mechanism observed for 
RIG-I stimulatory shRNAs. Furthermore, 
Chiu et al. report that interferon induction 
after infection of cells with adenovirus can 
be abrogated by pretreatment with the Pol 
III inhibitor ML-60218. While the mecha-
nism is not yet fully understood, it could 
be that the RNA Pol III encoded VA-I and 
VA-II transcripts are responsible for this 
effect.
Interestingly, Chiu et al. also advo-
cate a role for the RNA Pol III-dependent 
induction of Interferon-β in the immune 
response to the facultative intracellular, 
pathogenic bacteria Legionella pneumo-
phila. Indirect evidence already exists that, 
by means of its type IV secretion system, 
Legionella pneumophila injects DNA into 
the host cell cytoplasm that eventually leads 
to the induction of type I interferon. While 
a role for MAVS was postulated in mediat-
ing this effect, the same study negated the 
putative role of RIG-I.33 Studies in RIG-I 
deficient cells should help to clarify these 
discrepancies. In addition, specifying the 
genomic part that is responsible for the 
induction of interferon would be interest-
ing. In this regard, another important ques-
tion is whether this pathway is operational 
in the cytoplasm, in the nucleus or in both 
compartments. RNA Pol III is known to 
be mainly confined to the nucleus, yet 
there are reports that ascribe RNA Pol III 
functional activity in the cytoplasm as well. 
In fact, Chiu and colleagues have immu-
noprecipitated RNA Pol III subunits from 
cytosolic lysates, and, in addition, they have 
shown that RNA Pol III within cytosolic 
extracts can transcribe poly(dA:dT) into 
poly(rA:rU). Future studies that will be 
able to directly investigate the conversion of 
AT-rich DNA by RNA Pol III are required 
to clarify this phenomenon (Fig. 2).
transcription by RNA Pol III or that the 
resulting RNA transcript is ideally “suited” 
as a ligand for RIG-I. Chiu et al. found 
that RNA Pol III could not transcribe 
poly(dG:dC) into the cognate RNA tem-
plate. However, the question whether other 
homopolymeric DNA templates are con-
verted into stimulatory RNA species has not 
been answered so far. Nevertheless, due to 
its sequence complementarity, poly(rA:rU) 
forms a stable RNA duplex which renders it 
a strong ligand for RIG-I.
Immunostimulatory shRNAs are 
Sensed by RIG-I
On the basis of these findings, we next asked 
whether RIG-I was also involved in the 
response to Pol III transcribed interferon-
inducing shRNAs. Indeed, we found that 
the knock-down of RIG-I abrogated the 
IFNβ promoter activity of an interferon-
inducing shRNA construct expressed from 
a U6 promoter containing plasmid. Similar 
data were subsequently published by Tang 
and colleagues.31 Together these findings 
underscore the importance of the RNA Pol 
III—RIG-I—IFN—pathway, not only for 
promoter-independent transcription but 
also for RNA transcripts that are generated 
via the classical promoter-dependent path-
way. Our data form a connection between 
the interferon-inducing activity of shR-
NAs and their detection by the RNA heli-
case RIG-I. Importantly, this observation 
breaks with a previous hypothesis that the 
delivery of endogenous templates for medi-
ating RNAi would circumvent interferon 
induction of artificially introduced siRNAs 
and thus limit non specific effects.32
A Role for RNA Pol III in Pathogen 
Sensing
Finally, the intriguing question remained 
as to whether the RNA Pol III recognition 
pathway also operates in a physiological 
setting to recognize viruses on the basis 
of their genetic material. Although many 
DNA viruses hijack the host RNA poly-
merase system in the nucleus, the majority 
of their transcripts acquire—just like host 
genes—a variety of modifications including 
capping, nucleoside modifications or pro-
tection via binding to regulatory proteins. 
Through these mechanisms, a recognition 
RNA Pol III transcription complex. Of the 
17 RNA Pol III subunits, 10 are unique 
to RNA Pol III (RPC1-RPC10), two are 
shared between Pol I and Pol III (RPAC1, 
RPAC2) and five are common for all three 
Pols (RPABC1-RPABC5).29 Of the RNA 
Pol III specific subunits, RPC3, 6 and 7 
form a subcomplex that is detachable from 
the rest of the enzyme. It has been shown 
that these three subunits are not essential 
for elongation and termination but instead 
are required for the initiation of the tran-
scription process.30 Therefore, the finding 
that the conversion of poly(dA:dT) into 
poly(rA:rU) is not affected by the absence 
of RPC3 and RPC7 supports the idea of 
promoter-independent transcription. For 
Pol III promoters that contain a TATA-box, 
the transcription factor TFIIIB binds to 
DNA by the activity of its TBP subunit.29 
In their study Chiu et al. note that tran-
scription of poly(dA:dT) does not require 
TBP. Although the authors acknowledge 
that TBP might still play a role in the in 
vivo conversion process of poly(dA:dT) 
templates, TBP did not co-purify with the 
RNA Pol III complex that was sufficient for 
in vitro catalysation of RNA Pol III tran-
scription. Thus, this finding further sub-
stantiates the idea of promoter-independent 
transcription. However, Chiu et al. co-
purified RNA Pol III subunits using anti-
bodies targeting RPC6 and RPC7 (gene 
names POLR3F and PPOLR3G). While 
components of the subcomplex consisting 
of RPC3, RPC6 and RPC7 might also 
assemble on poly(dA:dT), their functional 
activity may not be necessary for the intrac-
ellular transcription of poly(dA:dT).
The next question was whether other 
artificially introduced DNA templates 
could also drive transcription by RNA Pol 
III and whether these were also able to exert 
the immunostimulatory response which 
was observed for poly(dA:dT). As would 
have been expected from the observations 
outlined above, randomly generated dsD-
NAs were unable to drive type I interferon 
production. In addition, Chiu et al. report 
that GCAT or GC sequences were unable 
to serve as templates for the synthesis of 
stimulatory RNA species, and the insertion 
of GCs into a homopolymeric poly(dA:dT) 
stretches abolished IFN-inducing activity. 
This suggests that some characteristic fea-
ture of poly(dA:dT) is either preferred for 
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Conclusion
In summary, these data have uncovered a 
novel pathway for the recognition of for-
eign DNA by RNA Pol III. Determining 
the functional contribution of RNA Pol 
III for the recognition of other infectious 
pathogens will be a notable advance in the 
field of innate immunity, yet it also poses 
significant technical challenges. One con-
sideration that hampers the straightforward 
investigation of the RNA Pol III pathway 
is the existence of additional, but so far 
uncharacterized, cytoplasmic or nuclear 
DNA-sensor(s) that could render the RNA 
Pol III pathway redundant. In addition, 
current effort is being spent to unravel the 
precise elements within shRNAs that ren-
der them immunostimulatory. Not only 
will this improve our understanding of 
endogenous RNAi routes, but this will also 
be of great benefit for the design of “safe” 
and highly selective shRNAs.
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